share_log

TherapeuticsMD | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Walker Marlan D

SEC announcement ·  May 4, 2023 16:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more